Alzamend Neuro, Inc.
ALZN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677077
In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Alzamend Neuro, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +5 vs. Q3 2024
- Shares held
- 113.3K
- +71.2K (+169.2%) vs. Q3 2024
- Total value
- $131.7K
- +$60.6K (+85.1%) vs. Q3 2024
- New holders
- 8
- 1 more added
- Sold out
- 3
- 1 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $3.26M |
| Q1 2026 | 13 | $723.1K |
| Q4 2025 | 13 | $447.2K |
| Q3 2025 | 11 | $351.3K |
| Q2 2025 | 7 | $6.36K |
| Q1 2025 | 11 | $59.9K |
| Q4 2024 | 17 | $131.7K |
| Q3 2024 | 12 | $71.2K |
| Q2 2024 | 16 | $150.5K |
| Q1 2024 | 13 | $386.8K |
| Q4 2023 | 16 | $334.7K |
| Q3 2023 | 27 | $1.49M |
| Q2 2023 | 24 | $3.13M |
| Q1 2023 | 26 | $2.64M |
| Q4 2022 | 33 | $3.98M |
| Q3 2022 | 17 | $9.41M |
| Q2 2022 | 21 | $2.70M |
| Q1 2022 | 22 | $4.01M |
| Q4 2021 | 20 | $1.66M |
| Q3 2021 | 17 | $1.99M |
| Q2 2021 | 11 | $2.58M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Alzamend Neuro, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 33,540 | $38.9K | 0.00% | +33,540 | New |
| Citadel Advisors LLC | 30,638 | $35.5K | 0.00% | +30,638 | New |
| Truist Financial Corp | 15,498 | $18.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 15,000 | $17.4K | 0.00% | +15,000 | New |
| Virtu Financial LLC | 12,719 | $15.0K | 0.00% | +12,719 | New |
| BlackRock, Inc. | 3,973 | $4.61K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 820 | $951 | 0.00% | +820 | New |
| Citigroup Inc | 544 | $631 | 0.00% | +544 | New |
| Tower Research Capital LLC (TRC) | 388 | $450 | 0.00% | −3,779−90.7% | Reduced |
| Bank of America Corp | 136 | $158 | 0.00% | +31+29.5% | Added |
| Harbor Investment Advisory, LLC | 20 | $23 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 20 | $23 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 18 | $21 | 0.00% | +18 | New |
| Advisor Group Holdings, Inc. | 6 | $7 | 0.00% | +6 | New |
| City State Bank | 4 | $5 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3 | $3 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 3 | $3 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,601−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −708−100.0% | Sold out |